Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden.

In this study, 796 men with unstable coronary artery disease (that is, unstable angina or non-Q wave myocardial infarction) were randomized to double-blind placebo-controlled treatment with aspirin (75 mg/day). The long-term efficacy was judged from the occurrence of myocardial infarction or death or severe angina necessitating referral to coronary angiography. The risk of myocardial infarction or death was reduced during aspirin treatment--after 1 year, the risk ratio was 0.52 (confidence interval 0.37 to 0.72). Severe angina necessitating referral to coronary angiography was less common during aspirin therapy--after 3 months, the risk ratio was 0.59 (0.42 to 0.84) and after 1 year 0.71 (0.56 to 0.91). The combined event rate of myocardial infarction or death or referral to coronary angiography was reduced; after 3 months, the risk ratio was 0.44 (0.30 to 0.66) and after 1 year 0.65 (0.54 to 0.79). The 75-mg aspirin dose was well tolerated and had a high level of patient compliance. Treatment with aspirin (75 mg/day) should be recommended to all men for greater than or equal to 3 months after an episode of unstable coronary artery disease. Long-term therapy should be considered if there are no contraindications or side effects.

[1]  C. Cimminiello,et al.  Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. , 1990, Circulation.

[2]  L. Wallentin,et al.  Predictive importance of clinical findings and a predischarge exercise test in patients with suspected unstable coronary artery disease. , 1987, The American journal of cardiology.

[3]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[4]  M. Winniford,et al.  Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. , 1984, The American journal of cardiology.

[5]  L. Wallentin,et al.  Effects of Ticlopidine of Platelet Function in Men with Stable Angina Pectoris , 1985, Thrombosis and Haemostasis.

[6]  C. Patrono.  Aspirin for the prevention of coronary thrombosis: current facts and perspectives. , 1986, European heart journal.

[7]  B. Weksler,et al.  Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. , 1983, The New England journal of medicine.

[8]  E. Falk.  Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.

[9]  V. Fuster,et al.  Insights into the pathogenesis of acute ischemic syndromes. , 1988, Circulation.

[10]  G. Remuzzi,et al.  Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. , 1989 .

[11]  D. Sackett,et al.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.

[12]  L. Wallentin,et al.  Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease. , 1991, European heart journal.

[13]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[14]  G. FitzGerald,et al.  Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. , 1983, The Journal of clinical investigation.

[15]  R J Prineas,et al.  International diagnostic criteria for acute myocardial infarction and acute stroke. , 1984, American heart journal.

[16]  J. Wittes,et al.  Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. , 1988, JAMA.

[17]  S. Chierchia,et al.  Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. , 1987, The New England journal of medicine.

[18]  V. Fuster,et al.  Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. , 1985, Journal of the American College of Cardiology.

[19]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[20]  J. Wittes,et al.  Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. , 1988, JAMA.

[21]  L. Wallentin,et al.  Early exercise testing after coronary care for suspected unstable coronary artery disease--safety and diagnostic value. , 1986, European heart journal.

[22]  S. Chierchia,et al.  Pathophysiology of coronary occlusion in acute infarction. , 1986, Circulation.

[23]  S. Epstein,et al.  Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy. , 1984, The American journal of cardiology.

[24]  R. Feldman.  Coronary thrombosis, coronary spasm and coronary atherosclerosis and speculation on the link between unstable angina and acute myocardial infarction. , 1987, The American journal of cardiology.

[25]  G. V. R. Born,et al.  INFLUENCE OF PLAQUE CONFIGURATION AND STRESS DISTRIBUTION ON FISSURING OF CORONARY ATHEROSCLEROTIC PLAQUES , 1989, The Lancet.

[26]  M. LeWinter,et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.

[27]  C. Madden.  Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease: The RISC Group Lancet 336: 827–830 Oct 1990 , 1991 .

[28]  C. Hawkey,et al.  Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. , 1989, BMJ.